Targeting retinoblastoma protein phosphorylation in combination with EGFR inhibition in pancreatic cancer cells

Pancreatic ductal adenocarcinoma (PDAC) remains a particularly lethal disease that is resistant to targeted therapies. Tyrosine kinase inhibitors (TKIs), including erlotinib and gefitinib, which block the action of the human epidermal growth factor receptor type 1 receptor, provide small increases i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Oncol
Asıl Yazarlar: Thomas, Nimmi A., Abraham, Rita G., Dedi, Brixhilda, Krucher, Nancy A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2018
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6317693/
https://ncbi.nlm.nih.gov/pubmed/30535494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4658
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller